GVR Report cover Corneal Implants Market Size, Share & Trends Report

Corneal Implants Market Size, Share & Trends Analysis Report By Type (Human Cornea, Synthetic), By Surgery Method, By Application (Keratoconus, Fuchs Dystrophy), By End User (Hospital, ASC), And Segment Forecasts, 2020 - 2027

  • Report ID: GVR-4-68038-655-4
  • Number of Pages: 130
  • Format: Electronic (PDF)
  • Historical Range: 2016 - 2018
  • Industry: Healthcare

Report Overview

The global corneal implants market size was valued at USD 386.4 million in 2019 and is anticipated to register a compound annual growth rate (CAGR) of 6.5% from 2020 to 2027. The increasing prevalence of ophthalmic diseases, such as keratoconus, Fuchs dystrophy, and infectious keratitis, is the key factor propelling the market growth. According to the NCBI report, approximately 10-15% of the patients diagnosed with keratoconus require to undergo a corneal implant procedure at some point. Corneal blindness is the third leading cause of blindness after glaucoma and cataract affecting 10 million people globally. It’s estimated that around 200,000 corneal implant procedures are performed annually. Whereas, still 12.7 million patients are waiting for corneal implants. This large gap between the demand and supply of corneal implants is expected to drive market growth over the forecast period.

U.S. corneal implant market size

Collagen-based bio-engineered artificial corneas have high demand in the market owing to their advantages, such as low cost, biocompatibility, and enhanced safety and effectiveness. For instance, LinkCor a collagen-based artificial cornea developed by LinkoCare Life Sciences Ltd. Is expected to be a potential substitute for human corneas. The product is currently under the regulatory and market approval process in several regions and is expected to be commercially available by 2020.

Increasing awareness about the importance of eye donation is expected to boost the market growth. In addition, improving eye care facilities, eye banking framework, and cornea trade protocols in developing countries are expected to contribute to the rising demand, thereby supporting market growth.

Type Insights

The synthetic type segment is estimated to register the fastest CAGR of 7.3% from 2020 to 2027. These implants are called artificial corneas and can be further classified as semi-synthetic (collagen-based) and purely synthetic (Polymethyl Methacrylate (PMMA) or titanium-based). Moreover, lack of human corneas coupled with the increasing prevalence of visual impairment due to corneal opacification is expected to drive the segment growth.

The human cornea segment held the largest market share of more than 50% in 2019 and is expected to register at a healthy CAGR over the forecast period. Enhanced Visual Acuity (VA) outcomes and the high success rate of the human cornea, which is reported to be as high as 95% with minimal repeated follow-ups, contribute to its largest market share.

Surgery Method Insights

The penetrating keratoplasty segment held the largest market share of more than 50% in 2019 and will remain dominant throughout the forecast years. However, the endothelial keratoplasty segment is expected to register the fastest CAGR from 2020 to 2027. Penetrating keratoplasty is the common procedure for corneal transplant owing to its known safety and efficacy.

According to the Eye Bank Association of America, 46% of the cornea produced by the eye bank were used for penetrating keratoplasty. In recent times, its adoption rate is slowly falling due to the availability of alternative methods showing promising results. However, its relative advantage over newer approaches, such as avoiding stromal interface and efficiency in treating large central perforations is expected to uphold its market share.

Endothelial keratoplasty is the newest approach in corneal transplant where only the affected tissue is replaced, rather than the full thickness of the cornea. This helps in faster and better visual restoration with decreased risk of infection and accidents to the eye surface. Moreover, with the growing prevalence of Fuchs Dystrophy, the segment is expected to grow at a significant rate during the forecast period.

End-user Insights

The hospital segment held the largest market share of over 55% in 2019 and is expected to register a lucrative CAGR over the forecast period. The presence of highly skilled surgeons, the rising number of patients, and access to transnational eye banks are the factors expected to drive the segment growth.

Global corneal implant marketshare

Ophthalmic centers accounted for the second-largest market share in 2019 and are expected to register a healthy growth rate over the forecast period. An increasing number of ophthalmologists entering practice, growing acceptance of keratoprosthesis, and shorter wait times are the factors expected to fuel the segment growth.

Ambulatory Surgical Center (ASC) segment is anticipated to register the maximum CAGR over the forecast period. Corneal implant procedures are performed on an outpatient basis in most care settings. Since it’s a single-day procedure, its adoption is anticipated to increase in ASCs. These centers are supported by several public and private funding projects.

Application Insights

Fuchs dystrophy segment held the largest market share with 52.5% in 2019 and is expected to grow at the fastest CAGR during the forecast period. The rising geriatric population, which is at a high risk of developing Fuchs dystrophy, is expected to drive the growth of the segment. Keratoconus also held a significant market share in 2019.

According to the Cancer Research Foundation of America, one in 5 keratoconus patients progresses to a stage where the corneal implant is needed to restore normal vision. In addition, the advent of advanced corneal implant procedures, such as Deep Anterior Lamellar Keratoplasty (DALK), and the availability of FDA-approved corneal implants are expected to boost the segment growth.

The application segment includes keratoconus, Fuchs dystrophy, infectious keratitis, corneal ulcers, and others. The application of corneal implants in post-surgical cataract edema, congenital corneal opacity, and mechanical or chemical damage to the cornea is included in the other segment.

Regional Insights

North America held the largest market share of around 59% in 2019. Domicile of major market players, efficient reimbursement policies, and increasing R&D activities related to corneal implants are the factors expected to drive the region’s growth further. For instance, CorneaGen has collaborated with the Institute of Regenerative Medicine to develop corneas from the replication of stem cells. Europe held the second-largest market share in 2019. Corneal implant procedures have improved markedly over the years in European countries, especially in the U.K., Germany, Italy, and Spain.

The region has faced a shortage of corneal tissue due to a decreased number of corneal donations. Moreover, the procurement of cornea from other countries is expensive and should also match the home resources. Considering this situation, the Opt-out system of organ donation has been adopted across countries in the region to promote corneal donation, thereby driving the market growth. Asia Pacific is expected to be the fastest-growing region over the forecast period. The presence of a number of emerging markets and highly unmet clinical needs in countries, such as China, Indonesia, and the Philippines, are expected to drive market growth.

Key Companies & Market Share Insights

The global market is highly fragmented. Major companies are implementing various business strategies, such as merger and acquisitions and product launches to enhance their market presence. For instance, In October 2019 CorneaGen raised USD 25 million through equity to fund its global market expansion strategy. Some of the prominent players in the corneal implants market include:

  • Florida Lions Eye Bank

  • Alcon, Inc.

  • Aurolab

  • CorneaGen

  • AJL Ophthalmic SA


  • Massachusetts Eye and Ear

  • San Diego Eye Bank

  • KeraMed, Inc.

  • Alabama Eye Bank, Inc.

Corneal Implants Market Report Scope

Report Attribute


Market size value in 2020

USD 411.67 million

Revenue forecast in 2027

USD 641.41 million

Growth Rate

CAGR of 6.5% from 2020 to 2027

Base year for estimation


Historical data

2016 - 2018

Forecast period

2020 - 2027

Quantitative units

Revenue in USD million and CAGR from 2020 to 2027

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Type, surgery method, application, end user, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Russia; Switzerland; The Netherlands; Sweden; Belgium; Japan; China; India; South Korea; Thailand; Indonesia; Philippines; Australia; Sri Lanka; Singapore; Brazil; Mexico; Argentina; Colombia; Chile; South Africa; Saudi Arabia; UAE; Kuwait; Israel

Key companies profiled

Florida Lions Eye Bank; Alcon, Inc.; Aurolab; CorneaGen; AJL Ophthalmic SA; DIOPTEX; Massachusetts Eye and Ear; San Diego Eye Bank; KeraMed, Inc.; Alabama Eye Bank, Inc.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2026. For the purpose of this study, Grand View Research has segmented the global corneal implants market report on the basis of type, surgery method, application, end user, and region:

  • Type Outlook (Revenue, USD Million, 2016 - 2027)

    • Human Cornea

    • Synthetic

  • Surgery Method Outlook (Revenue, USD Million, 2016 - 2027)

    • Penetrating Keratoplasty

    • Endothelial Keratoplasty

  • Application Outlook (Revenue, USD Million, 2016 - 2027)

    • Keratoconus

    • Fuchs Dystrophy

    • Infectious Keratitis

    • Corneal Ulcers

    • Others

  • End-user Outlook (Revenue, USD Million, 2016 - 2027)

    • Hospitals

    • Ophthalmic Center

    • Ambulatory Surgical Center

  • Regional Outlook (Revenue, USD Million, 2016 - 2027)

    • North America

      • The U.S.

      • Canada

    • Europe

      • The U.K.

      • Germany

      • France

      • Italy

      • Spain

      • Russia

      • Switzerland

      • The Netherlands

      • Sweden

      • Belgium

    • Asia Pacific

      • Japan

      • China

      • India

      • South Korea

      • Thailand

      • Indonesia

      • Philippines

      • Australia

      • Sri Lanka

      • Singapore

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

      • Chile

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

      • Israel

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.